Developer docs
API playgroundTry for free, no card

Search company profiles

BIOVOX

Full company profile

uuid0002tyq

Namestring
BIOVOX
Legal namestring
BIOVOX GmbH
Websiteurl
biovox.systems
Company typeenum
Private
Founded yearint
2021
Descriptiontext

BIOVOX GmbH is a Darmstadt-based materials company founded in 2021 that develops and sells Medical Grade bioplastic compounds to industrial buyers in the regulated healthcare sector. Its flagship MedEco portfolio comprises PLA-based, bio-PE-based, and high-transparency Perform grades formulated for injection molding, profile/tube/film extrusion, and extrusion blow molding, plus the Regiogradable® line of PBS-based compounds filled with regional organic residual materials (fruit peels, spent grains, wood waste, textiles) for hygiene, food-contact, and cosmetics applications. Each MedEco grade is supported by an ISO 13485-certified quality management system, ISO 10993 biocompatibility statements, regulatory information sheets, and LCA factsheets documenting up to 85% Cradle-to-Grave CO2 savings and freedom from PFAS, BPA, and phthalates. Materials are positioned as drop-in alternatives to PC/ABS at only a ~5–10% part-cost premium, frequently reaching price parity.

The company operates a pure B2B model, selling quote-priced granulate to OEMs, distributors, and packaging makers in MedTech, pharmaceutical, and laboratory sectors via direct enterprise sales, a Microsoft Bookings consultation funnel, trade fair presence (MedtecLIVE Stuttgart, Pharma Sustainability Days Geneva), and the co-founded BIOVOX Connect / Alliance for Sustainable Medical Technology network. Revenue mechanics are unit-volume sales of granulate under standard B2B General Terms and Conditions rather than subscriptions or licensing. Named enterprise relationships include Aesculap AG (B. Braun) via the B. Braun Accelerator Program, Röchling Medical (joint trocar redesign), and SoBiCo GmbH as a polymer supply partner, complemented by an unspecified life-science testimonial. Capital history consists of a mid-six-figure pre-seed round in April 2022 and a €2.2M seed round in September 2024 led by High-Tech Gründerfonds (HTGF), with no revenue disclosed to date.

Short descriptiontext

BIOVOX GmbH (Darmstadt, Germany; founded 2021) develops and sells ISO 13485-certified Medical Grade bioplastic compounds (MedEco, Regiogradable®) to B2B OEMs, distributors, and packaging makers in the MedTech, pharmaceutical, laboratory, hygiene, and food-contact sectors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDarmstadt, Germany
HQ citystring
Darmstadt
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical grade bioplastics, bioplastic compounds, medical device materials, pharmaceutical packaging plastics, sustainable bioplastics
Industry4 codes
PRIMARYIMAEAOAA
Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
  • Resin and Synthetic Rubber Manufacturing32521
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Medical Grade Bioplastics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1B2B sales of Medical Grade bioplastic compounds (granulates/pellets)
TypeHardware Sales
Description

Sales of MedEco and Regiogradable bioplastic compounds (units of material/granulate) to distributors and OEMs in the MedTech, pharmaceutical, and laboratory equipment sectors. The job description specifies BIOVOX is exclusively B2B, with only a "moderate" cost increase of ~5–10% over PC/ABS-based compounds observed in projects, often achieving price parity. Revenue is driven by unit volumes of bioplastic material sold to industrial customers rather than subscriptions or licensing.

biovox.systems
2General Terms and Conditions (B2B) governing material sales
TypeOne Time License
Description

Sales are governed by BIOVOX General Terms and Conditions (B2B) and General Terms and Conditions of Purchase, indicating standard commercial material supply transactions rather than subscription-based delivery.

biovox.systems
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Quote-based B2B pricing per project/application, negotiated directly with industrial customers (distributors and OEMs).
ModelUnit PricingBilling cadencePay-as-you-go
Notes

No public price list disclosed. Customers book a free consultation. In projects the company observes only ~5–10% higher part cost vs PC/ABS-based compounds, with frequent price parity; cost savings also come from thinner walls (cycle time/material reduction), shorter cycle times, and lower processing temperatures.

biovox.systems
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1BIOVOX MedEco
Description

Medical-grade bioplastic compound family (e.g., MedEco ICB, IGH, IPI, XCB, XGB, Perform ICH/XCI) for medical technology, pharma, hygiene, and laboratory applications.

biovox.systems
+2 more records
Core offering1 text field

BIOVOX develops, produces, and sells Medical Grade bioplastic compounds (granulates) under the MedEco brand for use in medical technology, pharmaceutical, and laboratory applications. The portfolio includes PLA-based grades (ICB, IGH, XCB), bio-PE-based grades (IPI, XPI), high-transparency sterilizable Perform grades (ICH, XCI), and the Regiogradable® upcycled PBS-based compound line for hygiene, food-contact, and cosmetics. All products are ISO 13485 certified, ISO 10993 biocompatible, and VDI 2017 Medical Grade, sold B2B to OEMs, distributors, and packaging manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Up to 85% CO2 reduction (Cradle-to-Grave) vs fossil plastics, and partly over 100% Cradle-to-Gate
+5 more records
Product overview1 text field

BIOVOX GmbH is a single-platform materials company that develops and supplies a portfolio of medical-grade bioplastic compounds under the "MedEco" brand (covering PLA-based grades such as MedEco ICB/IGH/XCB/XGB, bio-PE-based grades such as MedEco IPI/XPI, and the high-transparency sterilizable MedEco Perform ICH/XCI line) plus the upcycled, home-compostable "Regiogradable" PBS-based compound line for non-medical and consumer applications. These are complemented by a set of knowledge and consulting offerings: the open BioWiki knowledge base, the gated BE GREEN Compendium, the BIOVOX Connect network (co-founder of the Alliance for Sustainable Medical Technology), and material/design-for-sustainability consulting for medical device manufacturers. All products are sold B2B to OEMs, distributors, and packaging makers in medical technology, pharmaceutical, laboratory, hygiene, food, and cosmetics segments, backed by ISO 13485-certified quality management, ISO 10993 biocompatibility, and VDI 2017 Medical Grade quality.

Product and service4 records
1MedEco Bioplastics (Medical Grade Bioplastic Compound Family)
2Regiogradable® Bioplastics
CategoryUpcycled Bioplastics — Product Line
Description

Bio-based PBS (polybutylene succinate) compound filled with regional organic residual materials such as fruit peels, spent grains, wood waste, or textiles, turning waste streams into value. Home-compostable at 30°C, food-safe, vegan, microplastic-free, with no release of harmful substances or VOCs. Base material certified to DIN EN 13432. Available with various bio-based fillers and food-safe coloring options. Used in single-use hygiene products, food-contact products, and cosmetics.

3BIOVOX Connect
CategoryIndustry Network and Alliance
Description

Membership network for sustainable medical products and co-founder platform of the Alliance for Sustainable Medical Technology. Partners include BIOPRO Baden-Württemberg, Bayern Innovativ Gesundheit, Kompetenzzentrum Arbeitsforschung Komatra, and Forum MedTech Pharma. Members receive access to a member area with exclusive content including the Bioplastics Compendium, online sessions, and meetups covering topics such as sustainability as a change process, emerging green materials, and product development and design.

4Material Sustainability & Design-for-Sustainability Consulting
CategoryEngineering Consulting Service
Description

Consulting and engineering service that supports medical device manufacturers in re-designing products for sustainability. Services include FEM simulation, flow analysis, mass reduction engineering, monomaterial design for recycling, and modular design for reassembly. Demonstrated in a joint case study with Röchling Medical achieving over 50% CO2 footprint reduction and 32% material savings in a trocar re-design. Aimed at manufacturers in the medical technology sector.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Co-signatory of the MoU launching the Alliance for Sustainable Medical Technology (April 2024 group photo featuring Prof. Dr. Ralf Kindervater (BIOPRO), Dr. Jörg Traub (Forum MedTech Pharma), Dr. Julian Lotz (BIOVOX Connect)).

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-founder alongside BIOVOX of the Alliance for Sustainable Medical Technology (Allianz für nachhaltige Medizintechnik). Jointly organises online sessions on sustainability topics for the healthcare industry; alliance MoU signed 24 May 2023 in Nuremberg; visible joint press presence in Medizin & Technik and BIOPRO news.

3Gesundheit bei Bayern Innovativ
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance partner in the Alliance for Sustainable Medical Technology. Contributes its health innovation network to co-organised online sessions and joint ecosystem activities aimed at sustainable medical technology.

biovox.systems
4Kompetenzzentrum Arbeitsforschung Komatra
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance partner in the Alliance for Sustainable Medical Technology. Co-organises online sessions and joint stakeholder engagement in the healthcare industry on sustainability topics.

biovox.systems
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration within the B. Braun Accelerator Program, referenced as the foundation for ongoing cooperation; Dr. Jürgen Wegmann (Director Packaging Processing and R&D Processes, Aesculap AG) provided a public testimonial stating the collaboration with BIOVOX can help achieve B. Braun's sustainability goals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint best-practice re-design of a trocar (sterile single-use instrument for minimally invasive surgery) integrating Design-for-Sustainability principles and BIOVOX's bio-based PLA. The re-design achieved over 50% lower CO2 footprint and 32% material savings. Case study features Röchling Medical Senior Specialist R&D Erika Unjaev.

Strategic tierMinorTypeOthers
Description

Microsoft Bookings is integrated into the BIOVOX website to offer a free, no-obligation online appointment booking function for consultation requests. Data Processing Addendum in place per privacy policy.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

World's largest PLA producer (Ingeo biopolymer), with grades targeted at medical devices, packaging, and consumer goods. Directly comparable to BIOVOX as a PLA-based bioplastic resin supplier pushing into healthcare applications.

2Braskem
TypeBroad incumbent
Description

Brazilian petrochemical major producing I'm green bio-based polyethylene (sugarcane-derived) and increasingly exploring medical applications. Overlaps with BIOVOX's bio-PE MedEco grades and sustainability-driven MedTech/packaging customers, but at far larger scale.

TypeDirect peer
Description

German specialty compounder of bio-based and biodegradable plastics (Bio-Flex, Terralene, Ecovio-type compounds) sold to industrial converters. Mirrors BIOVOX's role as a curated bioplastic compounder with application-engineering support.

TypeDirect peer
Description

US-based producer of Nodax PHA biopolymers targeting packaging, foodservice, and specialty applications including potential medical use. Comparable as a bioplastic resin supplier positioning in regulated, sustainability-driven end markets.

TypeBroad incumbent
Description

Global chemical major offering bioplastic compounds such as Ecovio (PLA/PBAT blends) for packaging and other applications. Competes with BIOVOX in packaging and increasingly in medical plastics as part of a much broader portfolio.

TypeBroad incumbent
Description

Large German specialty chemicals company with medical-grade polymers (e.g., RESOMER bioresorbables, VESTAKEEP, VESTAMID) and broader sustainable plastics portfolio. Overlaps with BIOVOX on medical-grade quality and regulatory dossier support, but at significantly greater scale.

TypeDirect peer
Description

Italian developer of Mater-Bi bioplastics (bio-based and compostable) for packaging, food-service, and specialty applications. Comparable to BIOVOX as a bioplastic compounder selling into regulated end markets with a sustainability story.

TypeDirect peer
Description

Joint venture offering Luminy PLA bioplastics, including grades marketed for medical and packaging applications. Closely overlaps BIOVOX's MedEco PLA positioning and target end markets.

TypeEmerging player
Description

German specialty polymer distributor and compounder offering engineering and bio-based compounds, including grades for medical and industrial applications. Comparable to BIOVOX as a Europe-based, application-engineering-led bioplastic specialist.

TypeEmerging player
Description

Chinese manufacturer of modified and bio-based plastics with growing presence in medical, automotive, and packaging. Comparable to BIOVOX as a specialty bioplastic compounder targeting medical-grade and sustainability-led applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIOVOX

Medical Grade Bioplasticsbiovox.systems

BIOVOX GmbH (Darmstadt, Germany; founded 2021) develops and sells ISO 13485-certified Medical Grade bioplastic compounds (MedEco, Regiogradable®) to B2B OEMs, distributors, and packaging makers in the MedTech, pharmaceutical, laboratory, hygiene, and food-contact sectors.

What BIOVOX does

BIOVOX GmbH is a Darmstadt-based materials company founded in 2021 that develops and sells Medical Grade bioplastic compounds to industrial buyers in the regulated healthcare sector. Its flagship MedEco portfolio comprises PLA-based, bio-PE-based, and high-transparency Perform grades formulated for injection molding, profile/tube/film extrusion, and extrusion blow molding, plus the Regiogradable® line of PBS-based compounds filled with regional organic residual materials (fruit peels, spent grains, wood waste, textiles) for hygiene, food-contact, and cosmetics applications. Each MedEco grade is supported by an ISO 13485-certified quality management system, ISO 10993 biocompatibility statements, regulatory information sheets, and LCA factsheets documenting up to 85% Cradle-to-Grave CO2 savings and freedom from PFAS, BPA, and phthalates. Materials are positioned as drop-in alternatives to PC/ABS at only a ~5–10% part-cost premium, frequently reaching price parity.

The company operates a pure B2B model, selling quote-priced granulate to OEMs, distributors, and packaging makers in MedTech, pharmaceutical, and laboratory sectors via direct enterprise sales, a Microsoft Bookings consultation funnel, trade fair presence (MedtecLIVE Stuttgart, Pharma Sustainability Days Geneva), and the co-founded BIOVOX Connect / Alliance for Sustainable Medical Technology network. Revenue mechanics are unit-volume sales of granulate under standard B2B General Terms and Conditions rather than subscriptions or licensing. Named enterprise relationships include Aesculap AG (B. Braun) via the B. Braun Accelerator Program, Röchling Medical (joint trocar redesign), and SoBiCo GmbH as a polymer supply partner, complemented by an unspecified life-science testimonial. Capital history consists of a mid-six-figure pre-seed round in April 2022 and a €2.2M seed round in September 2024 led by High-Tech Gründerfonds (HTGF), with no revenue disclosed to date.

BIOVOX firmographics

Firmographics
Name
BIOVOX
Legal name
BIOVOX GmbH
Website
https://biovox.systems
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
BIOVOX GmbH (Darmstadt, Germany; founded 2021) develops and sells ISO 13485-certified Medical Grade bioplastic compounds (MedEco, Regiogradable®) to B2B OEMs, distributors, and packaging makers in the MedTech, pharmaceutical, laboratory, hygiene, and food-contact sectors.
Ownership category
akta.pro rank

BIOVOX industry classification

Industry
Product category
Medical Grade Bioplastics
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Resin and Synthetic Rubber Manufacturing (32521)
SIC
Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEAOAA
Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)

Keywords

  • Medical grade bioplastics
  • Bioplastic compounds
  • Medical device materials
  • Pharmaceutical packaging plastics
  • Sustainable bioplastics

Where BIOVOX is headquartered

Location

Headquarters

HQ city
Darmstadt
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

BIOVOX business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. B2B sales of Medical Grade bioplastic compounds (granulates/pellets): Sales of MedEco and Regiogradable bioplastic compounds (units of material/granulate) to distributors and OEMs in the MedTech, pharmaceutical, and laboratory equipment sectors. The job description specifies BIOVOX is exclusively B2B, with only a "moderate" cost increase of ~5–10% over PC/ABS-based compounds observed in projects, often achieving price parity. Revenue is driven by unit volumes of bioplastic material sold to industrial customers rather than subscriptions or licensing.
  2. General Terms and Conditions (B2B) governing material sales: Sales are governed by BIOVOX General Terms and Conditions (B2B) and General Terms and Conditions of Purchase, indicating standard commercial material supply transactions rather than subscription-based delivery.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goQuote-based B2B pricing per project/application, negotiated directly with industrial customers (distributors and OEMs).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

BIOVOX product offering

Product offering

Core offering

BIOVOX develops, produces, and sells Medical Grade bioplastic compounds (granulates) under the MedEco brand for use in medical technology, pharmaceutical, and laboratory applications. The portfolio includes PLA-based grades (ICB, IGH, XCB), bio-PE-based grades (IPI, XPI), high-transparency sterilizable Perform grades (ICH, XCI), and the Regiogradable® upcycled PBS-based compound line for hygiene, food-contact, and cosmetics. All products are ISO 13485 certified, ISO 10993 biocompatible, and VDI 2017 Medical Grade, sold B2B to OEMs, distributors, and packaging manufacturers.

Product overview

BIOVOX GmbH is a single-platform materials company that develops and supplies a portfolio of medical-grade bioplastic compounds under the "MedEco" brand (covering PLA-based grades such as MedEco ICB/IGH/XCB/XGB, bio-PE-based grades such as MedEco IPI/XPI, and the high-transparency sterilizable MedEco Perform ICH/XCI line) plus the upcycled, home-compostable "Regiogradable" PBS-based compound line for non-medical and consumer applications. These are complemented by a set of knowledge and consulting offerings: the open BioWiki knowledge base, the gated BE GREEN Compendium, the BIOVOX Connect network (co-founder of the Alliance for Sustainable Medical Technology), and material/design-for-sustainability consulting for medical device manufacturers. All products are sold B2B to OEMs, distributors, and packaging makers in medical technology, pharmaceutical, laboratory, hygiene, food, and cosmetics segments, backed by ISO 13485-certified quality management, ISO 10993 biocompatibility, and VDI 2017 Medical Grade quality.

Differentiator

Problem solved

Functional benefit

Brands

  • BIOVOX MedEco: Medical-grade bioplastic compound family (e.g., MedEco ICB, IGH, IPI, XCB, XGB, Perform ICH/XCI) for medical technology, pharma, hygiene, and laboratory applications.
  • BIOVOX Regiogradable
  • BIOVOX Connect

Products and services

  • MedEco Bioplastics (Medical Grade Bioplastic Compound Family)
  • Regiogradable® Bioplastics Bio-based PBS (polybutylene succinate) compound filled with regional organic residual materials such as fruit peels, spent grains, wood waste, or textiles, turning waste streams into value. Home-compostable at 30°C, food-safe, vegan, microplastic-free, with no release of harmful substances or VOCs. Base material certified to DIN EN 13432. Available with various bio-based fillers and food-safe coloring options. Used in single-use hygiene products, food-contact products, and cosmetics.
  • BIOVOX Connect Membership network for sustainable medical products and co-founder platform of the Alliance for Sustainable Medical Technology. Partners include BIOPRO Baden-Württemberg, Bayern Innovativ Gesundheit, Kompetenzzentrum Arbeitsforschung Komatra, and Forum MedTech Pharma. Members receive access to a member area with exclusive content including the Bioplastics Compendium, online sessions, and meetups covering topics such as sustainability as a change process, emerging green materials, and product development and design.
  • Material Sustainability & Design-for-Sustainability Consulting Consulting and engineering service that supports medical device manufacturers in re-designing products for sustainability. Services include FEM simulation, flow analysis, mass reduction engineering, monomaterial design for recycling, and modular design for reassembly. Demonstrated in a joint case study with Röchling Medical achieving over 50% CO2 footprint reduction and 32% material savings in a trocar re-design. Aimed at manufacturers in the medical technology sector.

Quantifiable outcome

  • Up to 85% CO2 reduction (Cradle-to-Grave) vs fossil plastics, and partly over 100% Cradle-to-Gate
  • +5 more outcomes

Companies that use BIOVOX

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

BIOVOX technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BIOVOX partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

  • Forum MedTech Pharma e.V.coreStrategic or Co-development Partner · 1 April 2024Co-signatory of the MoU launching the Alliance for Sustainable Medical Technology (April 2024 group photo featuring Prof. Dr. Ralf Kindervater (BIOPRO), Dr. Jörg Traub (Forum MedTech Pharma), Dr. Julian Lotz (BIOVOX Connect)).
  • BIOPRO Baden-Württemberg GmbHflagshipStrategic or Co-development PartnerCo-founder alongside BIOVOX of the Alliance for Sustainable Medical Technology (Allianz für nachhaltige Medizintechnik). Jointly organises online sessions on sustainability topics for the healthcare industry; alliance MoU signed 24 May 2023 in Nuremberg; visible joint press presence in Medizin & Technik and BIOPRO news.
  • Gesundheit bei Bayern InnovativcoreStrategic or Co-development PartnerAlliance partner in the Alliance for Sustainable Medical Technology. Contributes its health innovation network to co-organised online sessions and joint ecosystem activities aimed at sustainable medical technology.
  • Kompetenzzentrum Arbeitsforschung KomatracoreStrategic or Co-development PartnerAlliance partner in the Alliance for Sustainable Medical Technology. Co-organises online sessions and joint stakeholder engagement in the healthcare industry on sustainability topics.
  • B. Braun (Aesculap AG)coreStrategic or Co-development PartnerCollaboration within the B. Braun Accelerator Program, referenced as the foundation for ongoing cooperation; Dr. Jürgen Wegmann (Director Packaging Processing and R&D Processes, Aesculap AG) provided a public testimonial stating the collaboration with BIOVOX can help achieve B. Braun's sustainability goals.
  • Röchling MedicalcoreStrategic or Co-development PartnerJoint best-practice re-design of a trocar (sterile single-use instrument for minimally invasive surgery) integrating Design-for-Sustainability principles and BIOVOX's bio-based PLA. The re-design achieved over 50% lower CO2 footprint and 32% material savings. Case study features Röchling Medical Senior Specialist R&D Erika Unjaev.
  • Microsoft (Bookings)minorOthersMicrosoft Bookings is integrated into the BIOVOX website to offer a free, no-obligation online appointment booking function for consultation requests. Data Processing Addendum in place per privacy policy.
  • MailPoet (Aut O’Mattic A8C Ireland Ltd.)Others

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

BIOVOX competitors and assessment

Company assessment

Direct peers

  • NatureWorks: World's largest PLA producer (Ingeo biopolymer), with grades targeted at medical devices, packaging, and consumer goods. Directly comparable to BIOVOX as a PLA-based bioplastic resin supplier pushing into healthcare applications.
  • FKuR Kunststoff: German specialty compounder of bio-based and biodegradable plastics (Bio-Flex, Terralene, Ecovio-type compounds) sold to industrial converters. Mirrors BIOVOX's role as a curated bioplastic compounder with application-engineering support.
  • Danimer Scientific: US-based producer of Nodax PHA biopolymers targeting packaging, foodservice, and specialty applications including potential medical use. Comparable as a bioplastic resin supplier positioning in regulated, sustainability-driven end markets.
  • Novamont: Italian developer of Mater-Bi bioplastics (bio-based and compostable) for packaging, food-service, and specialty applications. Comparable to BIOVOX as a bioplastic compounder selling into regulated end markets with a sustainability story.
  • TotalEnergies Corbion: Joint venture offering Luminy PLA bioplastics, including grades marketed for medical and packaging applications. Closely overlaps BIOVOX's MedEco PLA positioning and target end markets.

Broad incumbents

  • Braskem: Brazilian petrochemical major producing I'm green bio-based polyethylene (sugarcane-derived) and increasingly exploring medical applications. Overlaps with BIOVOX's bio-PE MedEco grades and sustainability-driven MedTech/packaging customers, but at far larger scale.
  • BASF: Global chemical major offering bioplastic compounds such as Ecovio (PLA/PBAT blends) for packaging and other applications. Competes with BIOVOX in packaging and increasingly in medical plastics as part of a much broader portfolio.
  • Evonik: Large German specialty chemicals company with medical-grade polymers (e.g., RESOMER bioresorbables, VESTAKEEP, VESTAMID) and broader sustainable plastics portfolio. Overlaps with BIOVOX on medical-grade quality and regulatory dossier support, but at significantly greater scale.

Emerging players

  • LEHVOSS Group: German specialty polymer distributor and compounder offering engineering and bio-based compounds, including grades for medical and industrial applications. Comparable to BIOVOX as a Europe-based, application-engineering-led bioplastic specialist.
  • Kingfa Sci & Tech: Chinese manufacturer of modified and bio-based plastics with growing presence in medical, automotive, and packaging. Comparable to BIOVOX as a specialty bioplastic compounder targeting medical-grade and sustainability-led applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BIOVOX social profiles

Digital presence

BIOVOX compliance and trust

Trust signal

Compliance6 records

BIOVOX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIOVOX leadership team

Management profile

Number of profiles

Profiles3 records

BIOVOX subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BIOVOX funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIOVOX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOVOX

What does BIOVOX do?

BIOVOX develops, produces, and sells Medical Grade bioplastic compounds (granulates) under the MedEco brand for use in medical technology, pharmaceutical, and laboratory applications. The portfolio includes PLA-based grades (ICB, IGH, XCB), bio-PE-based grades (IPI, XPI), high-transparency sterilizable Perform grades (ICH, XCI), and the Regiogradable® upcycled PBS-based compound line for hygiene, food-contact, and cosmetics. All products are ISO 13485 certified, ISO 10993 biocompatible, and VDI 2017 Medical Grade, sold B2B to OEMs, distributors, and packaging manufacturers.

Is BIOVOX a public or private company?

BIOVOX is a private company. It is classified as venture growth investor backed and is currently operating.

When was BIOVOX founded?

BIOVOX was founded in 2021. It employs 1 to 10 people.

Where is BIOVOX based?

BIOVOX is headquartered in Darmstadt, Germany, in the Europe region.

How does BIOVOX make money?

Two revenue lines are on record. B2B sales of Medical Grade bioplastic compounds (granulates/pellets) is the primary driver. The others are general Terms and Conditions (B2B) governing material sales.

Who are BIOVOX's main competitors?

Direct peers on record are NatureWorks, FKuR Kunststoff, Danimer Scientific, Novamont and TotalEnergies Corbion. Broad incumbents are Braskem, BASF and Evonik. Emerging players are LEHVOSS Group and Kingfa Sci & Tech.

Does BIOVOX have an API?

No public API is recorded for BIOVOX.

What industry is BIOVOX in?

BIOVOX's product category is Medical Grade Bioplastics. Its primary akta.pro industry code is IMAEAOAA, Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 3254 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Plastics TodayBioplastics Gain Ground in Packaging and MedicalBASF and Biovox are advancing bioplastic technologies, with BASF expanding its ecovio compostable polymer portfolio for packaging and Biovox qualifying polylactic acid materials for medical-grade applications. These developments aim to meet regulatory compliance and sustainability goals, although the industry faces challenges regarding high production costs and limited barrier performance compared to conventional plastics.GlobeNewswireBioplastics in the Medical Industry Course: Upcoming Regulatory Changes and Market Trends That Will Shape Material Selection in Medical and Pharmaceutical Applications (ONLINE: Sept 29, 2026)ResearchAndMarkets.com added a training course on bioplastics in the medical industry, scheduled for Sept 29, 2026. The course covers regulatory changes, market trends, and material compliance, including bio-based and recycled plastics. It targets R&D, regulatory, and procurement professionals in healthcare.FinSMEsBiovox Closes €2.2M Seed FundingBiovox, a German company specializing in sustainable bioplastics for medical applications, has closed a €2.2 million seed funding round. The investment was led by High-Tech Gründerfonds with participation from Beteiligungs-Managementgesellschaft Hessen mbH and various other investors. Biovox intends to utilize these funds to accelerate the development and production of its portfolio of bioplastic solutions for the healthcare industry.StartseiteMaking Demanding Applications Bio-BasedBiovox, a German startup, develops bio-based plastics for demanding applications like healthcare consumables, targeting hospital waste which exceeds online retail plastic waste by about 50%. The company states that using 100% bio-based plastics in these applications reduces carbon emissions drastically, citing over 3 million tons of fossil carbon emissions annually from burning hospital plastics in Germany.medizin&technikStart-up Biovox entwickelt Biokunststoffe für MedizinprodukteBiovox, a Darmstadt-based startup founded in 2020, develops biobased, biodegradable plastics for medical devices and lab equipment. The company recently received a pre-seed investment of a mid-six-figure amount from Better Ventures and Auxxo Fund. It aims to become a market leader in bioplastics for medical products.StartbaseBiovox erhält mittleren sechsstelligen BetragBiovox, a Darmstadt-based company, raised a mid-six-figure pre-seed round from Better Ventures, Auxxo, and other investors. The company develops bioplastic materials for injection molding, extrusion, and 3D printing, aiming to reduce CO2 emissions compared to fossil plastics. The funds will expand labs and enable first products in series.StartbaseBiovox receives a mid-six-figure sumBiovox, a Darmstadt-based company, has raised a mid-six-figure sum in a pre-seed financing round to support its development of bioplastics that save CO2 emissions compared to fossil-based plastics. The funds will enable the expansion of Biovox's laboratories and technology as they prepare to begin series production of their initial products. The company aims to create bioplastics that are suitable for various applications in the medical, hygiene, and food industries, contributing to solutions for reducing climate impact.